title: Changes in metabolic profile among antiretroviral-naive patients initiating protease inhibitor versus non-protease inhibitor containing HAART regimens.
authors.forename: Fehmida
authors.initials: F
authors.lastname: Visnegarwala
authors.forename: Jorge
authors.initials: J
authors.lastname: Darcourt
authors.forename: Prasuna
authors.initials: P
authors.lastname: Sajja
authors.forename: Vandana
authors.initials: V
authors.lastname: Menon
authors.forename: Oliver
authors.initials: O
authors.lastname: Ong
authors.forename: Mario
authors.initials: M
authors.lastname: Maldonado
authors.forename: A Clinton
authors.initials: AC
authors.lastname: White
mesh_terms: D000328:Adult; D023241:Antiretroviral Therapy, Highly Active; D001786:Blood Glucose / Q000032:analysis; D015992:Body Mass Index; D015331:Cohort Studies; D005260:Female; D015658:HIV Infections / Q000097:blood / Q000188:drug therapy* / Q000378:metabolism; D017320:HIV Protease Inhibitors / Q000627:therapeutic use*; D006801:Humans; D007328:Insulin / Q000097:blood; D008055:Lipids / Q000097:blood; D008297:Male; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use*; D013997:Time Factors
chemical_list: D001786:Blood Glucose; D017320:HIV Protease Inhibitors; D007328:Insulin; D008055:Lipids; D018894:Reverse Transcriptase Inhibitors